Optical Coherence Domain Reflectometry and Optical Coherence Tomography Measurements of Intraocular Structure

Brief description of study

The purpose of the research to evaluate an ophthalmic imaging device called optical coherence tomography (OCT). This device is working like a camera acquiring images that has been shown to improve diagnosis and monitoring of eye diseases such as glaucoma, age-related macular degeneration, diabetic retinopathy, macular edema, and other pathologies. We are asking you to take part in this research study because you have a medical condition being studied and/or are scheduled to have test. This research study will be broken down into three groups of participants—cross-sectional, longitudinal, and reproducibility arms. The cross-sectional and longitudinal studies will help determine the effectiveness of the OCT technology in terms of detecting and monitoring eye diseases, while the reproducibility arm will test the measurement similarity of the OCT. Most procedures are approved by the Food and Drug Administration (FDA) with the exception of some OCT devices, which have been deemed non-significant risk devices. These devices meet the same standards set by the American National Standards Institute (ANSI) and therefore do no risk your health, safety, or welfare.


Clinical Study Identifier: s16-01302
ClinicalTrials.gov Identifier: NCT00286637
Principal Investigator: Chaim Wollstein.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.